Laboratorios Farmaceuticos Rovi, S.A. (FRA:41L)
Germany
· Delayed Price · Currency is EUR 60.05
+0.10 (0.17%)
At close: Dec 5, 2025
FRA:41L Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,061 | 3,220 | 3,213 | 1,925 | 4,138 | 2,099 | Upgrade
|
| Market Cap Growth | -6.48% | 0.22% | 66.93% | -53.49% | 97.10% | 55.36% | Upgrade
|
| Enterprise Value | 3,147 | 3,340 | 3,223 | 1,902 | 4,066 | 2,139 | Upgrade
|
| Last Close Price | 60.05 | 60.96 | 59.05 | 34.58 | 68.07 | 35.21 | Upgrade
|
| PE Ratio | 25.27 | 23.52 | 18.86 | 9.64 | 27.03 | 34.38 | Upgrade
|
| PS Ratio | 4.23 | 4.22 | 3.87 | 2.35 | 6.38 | 5.00 | Upgrade
|
| PB Ratio | 4.84 | 5.54 | 5.91 | 3.69 | 8.79 | 5.62 | Upgrade
|
| P/TBV Ratio | 5.22 | 5.92 | 6.28 | 3.92 | 9.42 | 6.18 | Upgrade
|
| P/FCF Ratio | 27.57 | 40.68 | 54.04 | 10.30 | 37.89 | 278.47 | Upgrade
|
| P/OCF Ratio | 17.54 | 23.29 | 28.37 | 8.10 | 27.69 | 44.79 | Upgrade
|
| EV/Sales Ratio | 4.35 | 4.37 | 3.89 | 2.33 | 6.27 | 5.09 | Upgrade
|
| EV/EBITDA Ratio | 17.57 | 16.73 | 13.54 | 7.01 | 20.69 | 23.87 | Upgrade
|
| EV/EBIT Ratio | 20.90 | 18.69 | 14.69 | 7.50 | 22.57 | 28.55 | Upgrade
|
| EV/FCF Ratio | 28.34 | 42.20 | 54.22 | 10.18 | 37.23 | 283.73 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.20 | 0.12 | 0.14 | 0.16 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.69 | 0.56 | 0.27 | 0.26 | 0.36 | 0.80 | Upgrade
|
| Debt / FCF Ratio | 1.11 | 1.45 | 1.10 | 0.39 | 0.67 | 9.87 | Upgrade
|
| Asset Turnover | 0.81 | 0.94 | 0.99 | 1.01 | 0.99 | 0.77 | Upgrade
|
| Inventory Turnover | 0.82 | 0.89 | 1.07 | 1.10 | 1.14 | 0.95 | Upgrade
|
| Quick Ratio | 1.30 | 0.99 | 0.83 | 1.04 | 1.35 | 1.10 | Upgrade
|
| Current Ratio | 3.02 | 3.13 | 2.55 | 2.12 | 2.66 | 2.97 | Upgrade
|
| Return on Equity (ROE) | 20.34% | 24.33% | 31.99% | 40.24% | 36.24% | 17.54% | Upgrade
|
| Return on Assets (ROA) | 10.46% | 13.69% | 16.34% | 19.68% | 17.23% | 8.63% | Upgrade
|
| Return on Capital (ROIC) | 13.05% | 17.12% | 22.81% | 27.88% | 22.69% | 10.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.40% | 26.50% | 36.60% | 43.40% | 33.20% | 16.60% | Upgrade
|
| Earnings Yield | 3.96% | 4.25% | 5.30% | 10.37% | 3.70% | 2.91% | Upgrade
|
| FCF Yield | 3.63% | 2.46% | 1.85% | 9.71% | 2.64% | 0.36% | Upgrade
|
| Dividend Yield | 1.26% | 1.53% | 1.87% | 3.74% | 1.40% | 1.08% | Upgrade
|
| Payout Ratio | 39.48% | 41.24% | 40.54% | 25.55% | 13.80% | 15.89% | Upgrade
|
| Buyback Yield / Dilution | - | 3.73% | 0.51% | 3.50% | -0.03% | -0.37% | Upgrade
|
| Total Shareholder Return | 1.26% | 5.26% | 2.38% | 7.24% | 1.37% | 0.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.